Dr Alison Marshall

Dr Alison Marshall

Lecturer

MA, PhD

Medicine & Health
The Kirby Institute

Alison is a Postdoctoral Fellow co-appointed at the Viral Hepatitis Clinical Research Program (the Kirby Institute) and the Centre for Social Research in Health at UNSW Sydney. In 2018, Alison received her PhD in clinical epidemiology at the Kirby Institute. Her PhD research utilised a mixed-methods approach (quantitative-qualitative design) with a primary focus on liver disease assessment, hepatitis C treatment uptake, and health policy. Prior to her PhD, Alison’s work involved multidisciplinary collaborations with international (WHO, PAHO) and national public health agencies (PHAC, CDC) to facilitate the uptake of evidence-based research in the development of hepatitis C policy, programs, and practices in global health settings.

Alison is also a current Fellow of the Canadian Institutes for Health Research (CIHR) funded program, the Canadian Network on Hepatitis C (CanHepC). Her most recent research is directed at remaining barriers to hepatitis C care in the interferon-free era for people who inject drugs.

Phone
+61 (2) 9385 9960
  • Journal articles | 2024
    Marshall AD; Rance J; Dore GJ; Grebely J; Treloar C, 2024, 'Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage Study', International Journal of Drug Policy, 129, http://dx.doi.org/10.1016/j.drugpo.2024.104477
    Journal articles | 2024
    Valerio H; Alavi M; Marshall AD; Hajarizadeh B; Amin J; Law M; Tillakeratne S; George J; Degenhardt L; Grebely J; Matthews GV; Dore GJ, 2024, 'Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia: A population-based study', Drug and Alcohol Review, 43, pp. 1080 - 1092, http://dx.doi.org/10.1111/dar.13688
    Journal articles | 2024
    Valerio H; Marshall AD; Conway A; Treloar C; Carter L; Martinello M; Henderson C; Amin J; Read P; Silk D; Degenhardt L; Prain B; Alavi M; Dore GJ; Grebely J, 2024, 'Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104394
    Journal articles | 2023
    Cheng Q; Bajis S; Cunningham E; Shih STF; Schulz M; Marshall AD; Martin NK; Miners A; Hajarizadeh B; Wiseman V; Dore GJ; Grebely J, 2023, 'Health-related quality of life among people who inject drugs in Australia', Quality of Life Research, 32, pp. 3195 - 3207, http://dx.doi.org/10.1007/s11136-023-03465-3
    Journal articles | 2023
    Clay S; Treloar C; Degenhardt L; Grebely J; Christmass M; Gough C; Hayllar J; McDonough M; Henderson C; Crawford S; Farrell M; Marshall A, 2023, '‘I just thought that was the best thing for me to do at this point’: Exploring patient experiences with depot buprenorphine and their motivations to discontinue', International Journal of Drug Policy, 115, http://dx.doi.org/10.1016/j.drugpo.2023.104002
    Journal articles | 2023
    Clay S; Wilkinson Z; Ginley M; Arunogiri S; Christmass M; Membrey D; MacCartney P; Sutherland R; Colledge-Frisby S; Marshall AD; Nagle J; Degenhardt L; Farrell M; McKetin R, 2023, 'Perspectives and sentiments on contingency management from people who use methamphetamine', Drug and Alcohol Review, 42, pp. 1427 - 1437, http://dx.doi.org/10.1111/dar.13691
    Journal articles | 2023
    Conway A; Krawczyk N; McGaffey F; Doyle S; Baaklini V; Marshall AD; Treloar C; Davis CS; Colledge-Frisby S; Grebely J; Cerdá M, 2023, 'Typology of laws restricting access to methadone treatment in the United States: A latent class analysis', International Journal of Drug Policy, 119, http://dx.doi.org/10.1016/j.drugpo.2023.104141
    Journal articles | 2023
    Conway A; Treloar C; Crawford S; Degenhardt L; Dore GJ; Farrell M; Hayllar J; Grebely J; Marshall AD, 2023, '“You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic', International Journal of Drug Policy, 114, http://dx.doi.org/10.1016/j.drugpo.2023.103998
    Journal articles | 2023
    Conway A; Treloar C; Crawford S; Grebely J; Marshall AD, 2023, 'People engaged in opioid agonist treatment as a counterpublic during the COVID-19 pandemic in Australia: A qualitative study', Drug and Alcohol Review, 42, pp. 203 - 212, http://dx.doi.org/10.1111/dar.13531
    Journal articles | 2023
    Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Marshall AD; Fontaine G; Conway A; Bajis S; Valencia BM; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Grebely J, 2023, 'Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis', International Journal of Drug Policy, 111, http://dx.doi.org/10.1016/j.drugpo.2022.103917
    Journal articles | 2023
    Lafferty L; Schroeder S; Marshall AD; Drysdale K; Higgs P; Stoové M; Baldry E; Dietze P; Treloar C, 2023, 'Trust and service engagement among people who inject drugs after release from prison', International Journal of Drug Policy, 111, http://dx.doi.org/10.1016/j.drugpo.2022.103925
    Journal articles | 2023
    Marshall AD; Martinello M; Zolopa C; Treloar C; Larney S, 2023, 'Universal hepatitis C virus screening and treatment as part of prenatal care', The Lancet Gastroenterology and Hepatology, 8, pp. 295 - 297, http://dx.doi.org/10.1016/S2468-1253(22)00421-6
    Journal articles | 2023
    Marshall AD; Schroeder SE; Lafferty L; Drysdale K; Baldry E; Stoové M; Dietze P; Higgs P; Treloar C, 2023, 'Perceived access to opioid agonist treatment in prison among people with a history of injection drug use: A qualitative study', Journal of Substance Use and Addiction Treatment, 150, http://dx.doi.org/10.1016/j.josat.2023.209066
    Journal articles | 2023
    Snell G; Marshall AD; van Gennip J; Bonn M; Butler-Mcphee J; Cooper CL; Kronfli N; Williams S; Bruneau J; Feld JJ; Janjua NZ; Klein M; Cunningham N; Grebely J; Bartlett SR, 2023, 'Public reimbursement policies in Canada for direct-acting antiviral treatment of hepatitis C virus infection: A descriptive study', Canadian Liver Journal, 6, pp. 190 - 200, http://dx.doi.org/10.3138/canlivj-2022-0040
    Journal articles | 2022
    Conway A; Valerio H; Alavi M; Silk D; Treloar C; Hajarizadeh B; Marshall AD; Martinello M; Milat A; Dunlop A; Murray C; Prain B; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Hayllar J; Reid D; Gorton C; Lam T; Christmass M; Wade A; Montebello M; Dore GJ; Grebely J, 2022, 'A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study', Viruses, 14, http://dx.doi.org/10.3390/v14071555
    Journal articles | 2022
    Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Marshall AD; Fontaine G; Conway A; Valencia BM; Bajis S; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Grebely J, 2022, 'Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis', The Lancet Gastroenterology and Hepatology, 7, pp. 426 - 445, http://dx.doi.org/10.1016/S2468-1253(21)00471-4
    Journal articles | 2022
    Horwitz R; Brener L; Marshall AD; Caruana T; Newman CE, 2022, 'Optimising community health services in Australia for populations affected by stigmatised infections: What do service users want?', Health and Social Care in the Community, 30, pp. e3686 - e3695, http://dx.doi.org/10.1111/hsc.14037
    Journal articles | 2022
    Larney S; Madden A; Marshall AD; Martin NK; Treloar C, 2022, 'A gender lens is needed in hepatitis C elimination research', International Journal of Drug Policy, 103, http://dx.doi.org/10.1016/j.drugpo.2022.103654
    Journal articles | 2022
    Marshall AD; Conway A; Cunningham EB; Valerio H; Silk D; Alavi M; Wade A; Lam T; Zohrab K; Dunlop A; Connelly C; Christmass M; Cock V; Burns C; Henderson C; Wiseman V; Dore GJ; Grebely J, 2022, 'Willingness of people who inject drugs to participate in a randomised controlled trial involving financial incentives to initiate hepatitis C treatment', Drug and Alcohol Dependence, 235, http://dx.doi.org/10.1016/j.drugalcdep.2022.109438
    Journal articles | 2022
    Marshall AD; Martinello M; Treloar C; Matthews GV, 2022, 'Perceptions of hepatitis C treatment and reinfection risk among HIV-positive men who have sex with men and engage in high risk behaviours for hepatitis C transmission: The CEASE qualitative study', International Journal of Drug Policy, 109, http://dx.doi.org/10.1016/j.drugpo.2022.103828
    Journal articles | 2022
    Marshall AD; Matthews GV, 2022, 'Simplifying hepatitis C care models: a crucial step towards hepatitis C elimination', The Lancet Gastroenterology and Hepatology, 7, pp. 1066 - 1068, http://dx.doi.org/10.1016/S2468-1253(22)00306-5
    Journal articles | 2022
    Marshall AD; Rance J; Grebely J; Treloar C, 2022, '‘Not just one box that you tick off’ – Deconstructing the hepatitis C care cascade in the interferon-free direct acting antiviral era from the client perspective', International Journal of Drug Policy, 102, http://dx.doi.org/10.1016/j.drugpo.2022.103610
    Journal articles | 2022
    Schroeder SE; Drysdale K; Lafferty L; Baldry E; Marshall AD; Higgs P; Dietze P; Stoove M; Treloar C, 2022, '"It's a revolving door": Ego-depletion among prisoners with injecting drug use histories as a barrier to post-release success', International Journal of Drug Policy, 101, pp. 103571, http://dx.doi.org/10.1016/j.drugpo.2021.103571
    Journal articles | 2021
    Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Christmass M; Dunlop A; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Treloar C; Dore GJ; Grebely J, 2021, 'Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103421
    Journal articles | 2021
    Grebely J; Collins AB; Artenie AA; Sutherland R; Meyer JP; Barocas JA; Falade-Nwulia O; Cepeda JA; Cunningham EB; Hajarizadeh B; Lafferty L; Lazarus JV; Bonn M; Marshall AD; Treloar C, 2021, 'Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103469
    Journal articles | 2021
    Treloar C; Schroeder S; Lafferty L; Marshall A; Drysdale K; Higgs P; Baldry E; Stoove M; Dietze P, 2021, 'Structural competency in the post-prison period for people who inject drugs: A qualitative case study', International Journal of Drug Policy, 95, pp. 103261, http://dx.doi.org/10.1016/j.drugpo.2021.103261
    Journal articles | 2020
    Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ; Peolim L; How-Chow D; Telenta J; Harvey P; Jones S; Dunlop A; Treloar C; Samuel Y; Poeder F; Crawford S; Baxter A; Keats J; Mowat Y; Silk D; Micallef M; Tamaddoni M; Marks P; Lamoury F; Jayasinghe I; Reid H; Cunningham EB; Bartlett S; Jacka B; Erratt A; Jauncey M; Collie P; Lam T; Gilliver R; Hazelwood S; Houlihan N; Burns C; Lewis R; Morris D; Donohue K; Carthew A; Horasak N; Cherry R; Shin S; Peterson D; Sellwood T; McKeown W; Pritchard-Jones J; Smyth F; Adey S; Clark K; Grebely J; Applegate T; Read P; Hajarizadeh B; Ezard N; Dore G; Edwards M, 2020, 'Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study', Journal of Viral Hepatitis, 27, pp. 281 - 293, http://dx.doi.org/10.1111/jvh.13233
    Journal articles | 2020
    Marshall AD; Grebely J; Dore GJ; Treloar C, 2020, 'Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists—The practitioner experience', Drug and Alcohol Dependence, 206, http://dx.doi.org/10.1016/j.drugalcdep.2019.107705
    Journal articles | 2020
    Marshall AD; Hopwood M; Grebely J; Treloar C, 2020, 'Applying a diffusion of innovations framework to the scale-up of direct-acting antiviral therapies for hepatitis C virus infection: Identified challenges for widespread implementation', International Journal of Drug Policy, 86, http://dx.doi.org/10.1016/j.drugpo.2020.102964
    Journal articles | 2019
    Marshall AD; Madden A; Treloar C, 2019, 'Enhancing engagement in hepatitis C care among people who inject drugs', Addiction, 114, pp. 2104 - 2106, http://dx.doi.org/10.1111/add.14698
    Journal articles | 2018
    Bajis S; Maher L; Treloar C; Hajarizadeh B; Lamoury FMJ; Mowat Y; Schulz M; Marshall AD; Cunningham EB; Cock V; Ezard N; Gorton C; Hayllar J; Smith J; Whelan M; Martinello M; Applegate TL; Dore GJ; Grebely J, 2018, 'Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia', International Journal of Drug Policy, 61, pp. 23 - 30, http://dx.doi.org/10.1016/j.drugpo.2018.08.011
    Journal articles | 2018
    Cheng ML; Abdel-Hakeem MS; Cousineau SE; Grebely J; Marshall AD; Saeed S; Sagan SM; Shoukry NH; Feld JJ; Macparland SA, 2018, 'The 7th canadian symposium on hepatitis c virus: “toward elimination of hcv: How to get there”', Canadian Liver Journal, 1, pp. 139 - 152, http://dx.doi.org/10.3138/canlivj.2018-0018
    Journal articles | 2018
    Lamoury FMJ; Bajis S; Hajarizadeh B; Marshall AD; Martinello M; Ivanova E; Catlett B; Mowat Y; Marks P; Amin J; Smith J; Ezard N; Cock V; Hayllar J; Persing DH; Kleman M; Cunningham P; Dore GJ; Applegate TL; Grebely J, 2018, 'Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay', Journal of Infectious Diseases, 217, pp. 1889 - 1896, http://dx.doi.org/10.1093/infdis/jiy114
    Journal articles | 2018
    Marshall AD; Cunningham EB; Nielsen S; Aghemo A; Alho H; Backmund M; Bruggmann P; Dalgard O; Seguin-Devaux C; Flisiak R; Foster GR; Gheorghe L; Goldberg D; Goulis I; Hickman M; Hoffmann P; Jancorienė L; Jarcuska P; Kåberg M; Kostrikis LG; Makara M; Maimets M; Marinho RT; Matičič M; Norris S; Ólafsson S; Øvrehus A; Pawlotsky JM; Pocock J; Robaeys G; Roncero C; Simonova M; Sperl J; Tait M; Tolmane I; Tomaselli S; van der Valk M; Vince A; Dore GJ; Lazarus JV; Grebely J, 2018, 'Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe', The Lancet Gastroenterology and Hepatology, 3, pp. 125 - 133, http://dx.doi.org/10.1016/S2468-1253(17)30284-4
    Journal articles | 2018
    Marshall AD; Pawlotsky JM; Lazarus JV; Aghemo A; Dore GJ; Grebely J, 2018, 'The removal of DAA restrictions in Europe – One step closer to eliminating HCV as a major public health threat', Journal of Hepatology, 69, pp. 1188 - 1196, http://dx.doi.org/10.1016/j.jhep.2018.06.016
    Journal articles | 2018
    Marshall AD; Treloar C; Dore GJ; Grebely J, 2018, 'A239 QUALITATIVE EVALUATION OF THE DECISIONS AND EXPERIENCES OF PEOPLE WHO INJECT DRUGS WHO RECEIVED A LIVER DISEASE ASSESSMENT AS PART OF A LIVER HEALTH PROMOTION CAMPAIGN: THE LIVERLIFE STUDY', Journal of the Canadian Association of Gastroenterology, 1, pp. 419 - 419, http://dx.doi.org/10.1093/jcag/gwy008.240
    Journal articles | 2018
    Neale J; Tompkins CNE; Marshall AD; Treloar C; Strang J, 2018, 'Building on feminist achievements to enhance choice for women seeking treatment', Addiction, 113, pp. 1001 - 1002, http://dx.doi.org/10.1111/add.14226
    Journal articles | 2018
    Neale J; Tompkins CNE; Marshall AD; Treloar C; Strang J, 2018, 'Do women with complex alcohol and other drug use histories want women-only residential treatment?', Addiction, 113, pp. 989 - 997, http://dx.doi.org/10.1111/add.14131
    Journal articles | 2017
    Bajis S; Lamoury F; Applegate TL; Maher L; Treloar C; Mowat Y; Schulz M; Hajarizadeh B; Marshall A; Cunningham E; Cock V; Ezard N; Gorton C; Hayllar J; Smith J; Dore GJ; Grebely J, 2017, 'P4 Acceptability of point of care finger-stick and venepuncture hepatitis C virus testing among people who inject drugs and homeless people', Journal of Virus Eradication, 3, pp. 13 - 14, http://dx.doi.org/10.1016/s2055-6640(20)30745-7
    Journal articles | 2017
    Grebely J; Lamoury FMJ; Hajarizadeh B; Mowat Y; Marshall AD; Bajis S; Marks P; Amin J; Smith J; Edwards M; Gorton C; Ezard N; Persing D; Kleman M; Cunningham P; Catlett B; Dore GJ; Applegate TL, 2017, 'Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study', The Lancet Gastroenterology and Hepatology, 2, pp. 514 - 520, http://dx.doi.org/10.1016/S2468-1253(17)30075-4
    Journal articles | 2017
    Marshall AD; Grebely J; Dore GJ; Treloar C, 2017, '‘I didn't want to let it go too far.’ The decisions and experiences of people who inject drugs who received a liver disease assessment as part of a liver health promotion campaign: The LiveRLife study', International Journal of Drug Policy, 47, pp. 153 - 160, http://dx.doi.org/10.1016/j.drugpo.2017.06.001
    Journal articles | 2017
    McPhail S; Schippers M; Marshall A, 2017, 'Development and Testing a Physical Activity Intervention for Ambulatory Older Patients During Rehabilitation', Archives of Physical Medicine and Rehabilitation, 98, pp. e21 - e22, http://dx.doi.org/10.1016/j.apmr.2017.08.066
    Journal articles | 2016
    Marshall AD; Saeed S; Barrett L; Cooper CL; Treloar C; Bruneau J; Feld JJ; Gallagher L; Klein MB; Krajden M; Shoukry NH; Taylor LE; Grebely J; Canadian Network on Hepatitis C (CanHepC) , 2016, 'Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study.', CMAJ Open, 4, pp. E605 - E614, http://dx.doi.org/10.9778/cmajo.20160008
    Journal articles | 2016
    Van Buuren N; Fradette L; Grebely J; King A; Krajden M; Macparland SA; Marshall A; Saeed S; Wilson J; Klein MB; Sagan SM, 2016, 'The 5th Canadian Symposium on Hepatitis C Virus: We Are Not Done Yet - Remaining Challenges in Hepatitis C', Canadian Journal of Gastroenterology and Hepatology, 2016, pp. 7603526, http://dx.doi.org/10.1155/2016/7603526
    Journal articles | 2015
    Marshall AD; Micallef M; Erratt A; Telenta J; Treloar C; Everingham H; Jones SC; Bath N; How-Chow D; Byrne J; Harvey P; Dunlop A; Jauncey M; Read P; Collie T; Dore GJ; Grebely J, 2015, 'Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study', International Journal of Drug Policy, 26, pp. 984 - 991, http://dx.doi.org/10.1016/j.drugpo.2015.07.002
    Journal articles | 2012
    Eakin E; Reeves M; Dunstan D; Healy G; Winkler E; Marshall A; Owen N, 2012, 'Living well with Diabetes: Six-month randomised trial outcomes of a telephone-delivered weight loss intervention', Journal of Science and Medicine in Sport, 15, pp. S202 - S202, http://dx.doi.org/10.1016/j.jsams.2012.11.492
    Journal articles | 2011
    Brosseau L; Wells GA; Tugwell P; Egan M; Dubouloz CJ; Casimiro L; Bugnariu N; Welch VA; De Angelis G; Francoeur L; Milne S; Loew L; Mcewan J; Messier SP; Doucet E; Kenny GP; Prud'homme D; Lineker S; Bell M; Poitras S; Li JX; Finestone HM; Laferrière L; Haines-Wangda A; Russell-Doreleyers M; Lambert K; Marshall AD; Cartizzone M; Teav A, 2011, 'Ottawa Panel evidence-based linical practice guidelines for the anagement of osteoarthritis in dults who are obese or overweight', Physical Therapy, 91, pp. 843 - 861, http://dx.doi.org/10.2522/ptj.20100104
    Journal articles | 2008
    Brosseau L; Wells GA; Tugwell P; Egan M; Wilson KG; Dubouloz CJ; Casimiro L; Robinson VA; McGowan J; Busch A; Poitras S; Moldofsky H; Harth M; Finestone HM; Nielson W; Haines-Wangda A; Russell-Doreleyers M; Lambert K; Marshall AD; Veilleux L, 2008, 'Ottawa panel evidence-based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: Part 1', Physical Therapy, 88, pp. 857 - 871, http://dx.doi.org/10.2522/ptj.20070200
    Journal articles | 2008
    Brosseau L; Wells GA; Tugwell P; Egan M; Wilson KG; Dubouloz CJ; Casimiro L; Robinson VA; McGowan J; Busch A; Poitras S; Moldofsky H; Harth M; Finestone HM; Nielson W; Haines-Wangda A; Russell-Doreleyers M; Lambert K; Marshall AD; Veilleux L, 2008, 'Ottawa panel evidence-based clinical practice guidelines for strengthening exercises in the management of fibromyalgia: Part 2', Physical Therapy, 88, pp. 873 - 886, http://dx.doi.org/10.2522/ptj.20070115
  • Conference Papers | 2022
    Clay S; Treloar C; Degenhardt L; Grebely J; Farrell M; Marshall AD, 2022, 'Options: Exploring patients' experiences with depot buprenorphine and their motivations to discontinue', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S43 - S43, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700076&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2022
    Treloar C; Broady T; Drysdale K; Brener L; Schroeder SE; Lafferty L; Marshall AD; Dietze PM; Higgs P; Stoove M; Baldry E, 2022, 'Changing attitudes of the general public towards people with prison and injecting drug use histories: A research-informed, co-designed, arts-based intervention', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S136 - S137, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700234&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2021
    Conway A; Treloar C; Crawford S; Degenhardt L; Dore GJ; Farrell M; Grebely J; Marshall AD, 2021, '"WE'VE HAD A CIRCUIT BREAKER FOR AN OLD DOGMA OF MORE THAN 20 YEARS": CHANGES TO OPIOID AGONIST TREATMENT SERVICES DURING COVID-19, THE CHOICE STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S59 - S59, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200148&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2021
    Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Amin J; Christmass M; Dunlop AJ; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Dore GJ; Treloar C; Grebely J, 2021, 'OPIOID OVERDOSE AND NALOXONE ACCESS AMONG PEOPLE WHO RECENTLY USED OPIOIDS OR RECEIVED OPIOID AGONIST TREATMENT IN AUSTRALIA: THE ETHOS ENGAGE STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S59 - S60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200149&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2021
    Marshall AD; Crawford S, 2021, 'MINI SYMPOSIUM: INTERVENTIONS TO IMPROVE ACCESS TO HEPATITIS C TESTING AND TREATMENT FOR PEOPLE WHO USE DRUGS', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S28 - S28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200069&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Reports | 2020
    Brener L; Horwitz R; Marshall A; Newman C, 2020, Impact of stigma and discrimination experienced by priority populations affected by STIs and BBVs in the ACT, Centre for Social Research in Health, UNSW Sydney, Sydney
    Conference Abstracts | 2019
    Hajarizadeh B; Marshall AD; Grebely J; Dore GJ; Treloar C; Corry A; Hayllar J; Byrne J, 2019, 'SYMPOSIUM: ENHANCING HEPATITIS C CARE AMONG PEOPLE WHO INJECT DRUGS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S8 - S9, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2019
    Marshall AD; Grebely J; Dore GJ; Treloar C, 2019, 'BARRIERS AND FACILITATORS TO ENGAGING IN HEPATITIS C MANAGEMENT AND DIRECT-ACTING ANTIVIRAL THERAPY AMONG GENERAL PRACTITIONERS AND DRUG AND ALCOHOL SPECIALISTS: THE PRACTITIONER EXPERIENCE', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S9 - S9, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100019&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2019
    Neale J; Tompkins CNE; Marshall AD; Treloar C; Strang J, 2019, 'DO WOMEN WITH COMPLEX ALCOHOL AND OTHER DRUG USE HISTORIES WANT WOMEN-ONLY RESIDENTIAL TREATMENT?', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S76 - S76, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100192&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2018
    Lamoury F; Bajis S; Hajarizadeh B; Marshall A; Martinello M; Ivanova E; Catlett B; Mowat Y; Marks P; Amin J; Smith J; Ezard N; Cock V; Hayllar J; Persing D; Kleman M; Cunningham P; Dore G; Applegate T; Grebely J, 2018, 'Evaluation of the Xpert fingerstick HCV viral load assay', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. S167 - S167, presented at International Liver Congress (ILC), FRANCE, Paris, 11 April 2018 - 15 April 2018, http://dx.doi.org/10.1016/S0168-8278(18)30546-4
    Other | 2018
    Lancaster K; Marshall A; Dertadian G; Yates K; Rance J, 2018, Qualitative Methods Journal Club July 2018 - ‘Sending the Wrong Signal’, Society for the Study of Addiction, , https://www.addiction-ssa.org/commentary/qmjc-july-2018-sending-the-wrong-signal
    Other | 2018
    Lancaster K; Marshall A; Dertadian G; Yates K; Rance J, 2018, Qualitative Methods Journal Club June 2018 - Conceiving of addicted pleasures, Society for the Study of Addiction, , https://www.addiction-ssa.org/commentary/qmjc-june-2018-conceiving-of-addicted-pleasures
    Other | 2018
    Lancaster K; Marshall A; dertadian G; yates K; Rance J, 2018, Qualitative Methods Journal Club May 2018 - Why am I the way I am?, Society for the Study of Addiction, , https://www.addiction-ssa.org/commentary/qmjc-may-2018-why-am-i-the-way-i-am
    Other | 2018
    Marshall A; Lancaster K; Dertadian G; Yates K; Rance J, 2018, Qualitative Methods Journal Club April 2018 - Sleeping at the Margins, , https://www.addiction-ssa.org/commentary/qmjc-april-2018-sleeping-at-the-margins
    Other | 2018
    Marshall A; Lancaster K; Dertadian G; Yates K; Rance J, 2018, Qualitative Methods Journal Club February 2018 - Parents Who Use Drugs, Society for the Study of Addiction, , https://www.addiction-ssa.org/commentary/qmjc-feb-2018-parents-who-use-drugs
    Other | 2018
    marshall A; Lancaster K; Dertadian G; Yates K; Rance J, 2018, Qualitative Methods Journal Club March 2018 - Ethnography and Injecting Drug Use, Society for the Study of Addiction, , https://www.addiction-ssa.org/commentary/qmjc-mar-2018-ethnography-and-injecting-drug-use
    Conference Papers | 2017
    Grebely J; Lamoury F; Hajarizadeh B; Mowat Y; Marshall A; Bajis S; Marks P; Amin J; Smith J; Edwards M; Gorton C; Ezard N; Persing D; Kleman M; Cunningham P; Catlett B; Dore G; Applegate TL, 2017, 'Field evaluation of Xpert (R) HCV Viral Load point-of-care test for detection of hepatitis C virus infection by venipuncture-collected and finger-stick capillary whole-blood samples', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, pp. S709 - S709, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)31900-1
    Conference Abstracts | 2017
    Marshall AD; Nielsen S; Cunningham EB; Aghemo A; Alho H; Backmund M; Bruggmann P; Dalgard O; Flisiak R; Foster G; Gheorghe L; Goldberg D; Goulis I; Hickman M; Hoffmann P; Jancoriene L; Jarcuska P; Kaberg M; Makara M; Maimets M; Marinho R; Maticic M; Norris S; Olafsson S; Ovrehus A; Pawlotsky J-M; Pocock J; Robaeys G; Roncero C; Simonova M; Sperl J; Tait M; Tolmane I; Tomaselli S; van der Valk M; Vince A; Dore GJ; Lazarus JV; Grebely J, 2017, 'Restrictions for reimbursement of interferon-free direct-acting antiviral therapies for HCV infection in Europe', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, Vol. 66, pp. S95 - S96, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)30450-6
    Conference Abstracts | 2016
    Grebely J; Marshall AD; Krahe M; Erratt A; Telenta J; Treloar C; Jones SC; Adey S; Bath N; How-Chow D; Byrne J; Harvey P; Dunlop AJ; Applegate TL; Lamoury F; Mowat Y; Jauncey M; Read P; Gilliver R; Smith J; Collie T; Dore GJ, 2016, 'A LIVER HEALTH PROMOTION INTERVENTION INTEGRATING NON-INVASIVE LIVER DISEASE SCREENING IN DRUG AND ALCOHOL SETTINGS: THE LIVERLIFE STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 40 - 40